Search by Drug Name or NDC
NDC 59651-0214-30 AZELASTINE HYDROCHLORIDE 137 ug/1 Details
AZELASTINE HYDROCHLORIDE 137 ug/1
AZELASTINE HYDROCHLORIDE is a NASAL SPRAY, METERED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is AZELASTINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Azelastine, an antihistamine, is used to treat hay fever and allergy symptoms including runny nose, sneezing, and itchy nose. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 59651-0214-30Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Azelastine Nasal Spray
Product Information
| NDC | 59651-0214 |
|---|---|
| Product ID | 59651-214_962105c0-2e59-4d00-805a-f28f76088ef5 |
| Associated GPIs | 42401015102020 |
| GCN Sequence Number | 029893 |
| GCN Sequence Number Description | azelastine HCl SPRAY/PUMP 137 MCG NASAL |
| HIC3 | Q7E |
| HIC3 Description | NASAL ANTIHISTAMINE |
| GCN | 60544 |
| HICL Sequence Number | 007607 |
| HICL Sequence Number Description | AZELASTINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | AZELASTINE HYDROCHLORIDE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | AZELASTINE HYDROCHLORIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SPRAY, METERED |
| Route | NASAL |
| Active Ingredient Strength | 137 |
| Active Ingredient Units | ug/1 |
| Substance Name | AZELASTINE HYDROCHLORIDE |
| Labeler Name | Aurobindo Pharma Limited |
| Pharmaceutical Class | Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA212289 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 59651-0214-30 (59651021430)
| NDC Package Code | 59651-214-30 |
|---|---|
| Billing NDC | 59651021430 |
| Package | 1 BOTTLE, SPRAY in 1 CARTON (59651-214-30) / 200 SPRAY, METERED in 1 BOTTLE, SPRAY |
| Marketing Start Date | 2020-05-08 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.2952 |
| Pricing Unit | ML |
| Effective Date | 2024-02-21 |
| NDC Description | AZELASTINE 0.1% (137 MCG) SPRY |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis